Professor Weibo Cai, PhD has received three grants within the past month to help fund his research initiatives. These three grants total to over $400,000 and will facilitate various research projects for the Cai Research Group, which focuses on molecular imaging and nanotechnology.
The first grant is from the UW-Madison Graduate School Fall Competition, and starts on July 1st, 2021. The proposal, titled “DNA Nanostructures for Treatment of Acute Kidney Injury”, will be used to gather more data for R01 submission to the NIH. Dr. Cai received his second grant from Focus-X Therapeutics, Inc, which starts on January 1st, 2021. This industry-sponsored research agreement focuses on developing novel anti-cancer radiopharmaceuticals for imaging and therapy, with the goal of starting Phase I and II clinical trials in the near future. The third grant was provided by the UW-Madison Office of the Vice Chancellor for Research and Graduate Education, with funding from the Wisconsin Alumni Research Foundation. This grant, which also starts on January 1st, is flexible funding that will be used on different molecular imaging and nanotechnology projects.
Dr. Cai is excited about these grants and how they will support research projects in his lab. “We are delighted to receive three grants over the last month, which cover a broad scope of molecular imaging, nanobiotechnology, and translational research, with a clear goal of moving the best radiopharmaceuticals into clinical trials so we can benefit cancer patients in the near future,” says Dr. Cai